Categories: Analysis

Earnings Preview: PetIQ’s third quarter might come as a treat

PetIQ Inc. (PETQ) is scheduled to report earnings results for the third quarter of 2018 on Tuesday, November 13, after the market closes. Revenue is expected to grow nearly 107% year-over-year to $125 million while earnings are expected to decline 13% to $0.25 per share. The company has consistently beat EPS estimates over the past four quarters and can be expected to do so in the third quarter as well.

In the second quarter, the company delivered earnings of $0.66 per share on revenue of $171 million, both of which surpassed analysts’ expectations. Revenue grew 96% during the quarter from the prior-year period, reflecting growth in retail partners and expansion of product and services offerings.

PetIQ posted revenue increases in both its Products and Services segments during the second quarter. The company opened 17 wellness centers and three regional offices during the quarter, marking the completion of all 20 VetIQ wellness centers.

In the second quarter, the company raised its full-year 2018 consolidated net sales guidance to approx. $500 million, reflecting a year-over-year increase of around 88%. Adjusted EBITDA is expected to come in a range of $40 million to $45 million, reflecting an increase of 79% to 102% year-over-year.

Cardinal Health posts better-than-expected Q1 earnings

In October, PetIQ acquired pet supplements-maker HBH Enterprises, in a cash-and-stock deal. The transaction is not expected to materially impact fourth-quarter 2018 results, so the full-year guidance remains unchanged. The deal is expected to be accretive in 2019.

The momentum from the company’s product and service offerings as well as its new wellness centers is likely to continue for the third quarter and can be helpful in driving growth. Updates relating to the new HBH subsidiary are another area to keep an eye on. Overall, PetIQ appears to be on track to deliver another earnings surprise for the third quarter.

PetIQ’s stock has gained 54% so far this year and looking at the past three months, the stock has climbed 23%. If the company beats estimates for the third quarter, the stock is likely to get a lift.

 

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Share
Published by

Recent Posts

Fiserv (FISV) Earnings: 4Q25 Key Numbers

Fiserv Inc. (NASDAQ: FISV) reported its fourth quarter 2025 earnings results today. Revenue increased 1%…

19 seconds ago

Incyte Corporation Reports Strong 2025 Fiscal Results and Provides 2026 Guidance

Incyte achieved total revenue of $5.14 billion for the full year 2025, a 21% year-over-year…

3 minutes ago

CVS Health Reports Record 2025 Revenue of $402.1 Billion and Reaffirms 2026 Earnings Guidance

CVS Health Corporation (NYSE: CVS) reported record full-year 2025 consolidated revenues of $402.1 billion, a…

26 minutes ago

CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline

Healthcare solutions company CVS Health Corporation (NYSE: CVS) on Monday reported an increase in revenues…

41 minutes ago

DuPont Reports 2025 Full-Year Results and Issues 2026 Guidance Following Strategic Spinoffs

The industrial materials manufacturer reported flat fourth-quarter sales and a full-year organic growth rate of…

48 minutes ago

Harley-Davidson Q4 2025 Results Reflect Margin Pressure

Overview Harley-Davidson, Inc. reported consolidated fourth-quarter 2025 results that point to continued pressure on profitability…

60 minutes ago